Chiral Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine and its Phase I and II Metabolites following Controlled Administration to Humans

Drug Metabolism and Disposition : the Biological Fate of Chemicals
Andrea E SteuerThomas Kraemer

Abstract

Generally, pharmacokinetic studies on 3,4-methylenedioxymethamphetamine (MDMA) in blood have been performed after conjugate cleavage, without taking into account that phase II metabolites represent distinct chemical entities with their own effects and stereoselective pharmacokinetics. The aim of the present study was to stereoselectively investigate the pharmacokinetics of intact glucuronide and sulfate metabolites of MDMA in blood plasma after a controlled single MDMA dose. Plasma samples from 16 healthy participants receiving 125 mg of MDMA orally in a controlled study were analyzed using liquid chromatography-tandem mass spectroscopy after chiral derivatization. Pharmacokinetic parameters of R- and S-stereoisomers were determined. Sulfates of 3,4-dihydroxymethamphetamine (DHMA), and sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA) were identified, whereas free phase I metabolites were not detected. Stereoselective differences in Cmax and AUC24 were observed with the following preferences: R>S for MDMA and DHMA 4-sulfate; S>R for 3,4-methylenedioxyamphetamine (MDA), DHMA 3-sulfate, and HMMA glucuronide; and no preference in Cmax for HMMA sulfate. R/S ratios were >1 for all analytes after 24 hours, independ...Continue Reading

References

Feb 15, 2000·British Journal of Clinical Pharmacology·Rafael de la TorreJordi Camí
Mar 18, 2000·Toxicology Letters·Hans H MaurerFrank T Peters
Nov 21, 2000·Annals of the New York Academy of Sciences· de la Torre RJordi Camí
Feb 13, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Matthias E LiechtiF X Vollenweider
Sep 18, 2001·Chemical Research in Toxicology·Mireia SeguraRafael de la Torre
Jun 20, 2003·The Pharmacogenomics Journal·C Guillemette
Jul 2, 2004·Therapeutic Drug Monitoring·Rafael de la TorreJordi Camí
Mar 3, 2006·Journal of Psychopharmacology·Neil Easton, Charles A Marsden
Aug 30, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Markus R MeyerHans H Maurer
Apr 18, 2009·Molecular Neurobiology·João Paulo CapelaFélix Carvalho
Jul 25, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Melanie MuellerGeorge A Ricaurte
Apr 15, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Irene Antolino-LoboMajorie B M van Duursen
Mar 7, 2012·Archives of Toxicology·Márcia CarvalhoMaria de Lourdes Bastos
Oct 8, 2013·Social Cognitive and Affective Neuroscience·Cédric M HysekMatthias E Liechti
Dec 18, 2013·British Journal of Pharmacology·Charles W SchindlerMichael H Baumann
Feb 7, 2015·The Journal of Pharmacology and Experimental Therapeutics·Yasmin SchmidMatthias E Liechti
Jun 16, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Magí FarréRafael de la Torre

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Separation Anxiety

Separation anxiety is a type of anxiety disorder that involves excessive distress and anxiety with separation. This may include separation from places or people to which they have a strong emotional connection with. It often affects children more than adults. Here is the latest research on separation anxiety.

KIF1A Associated Neurological Disorder

KIF1A associated neurological disorder (KAND) is a rare neurodegenerative condition caused by mutations in the KIF1A gene. KAND may present with a wide range and severity of symptoms including stiff or weak leg muscles, low muscle tone, a lack of muscle coordination and balance, and intellectual disability. Find the latest research on KAND here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.